A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure

Neuroscience Letters

Volumn 514, Issue 1, 2012, Pages 110-115

  Yu, Nian ^a   Di, Qing ^a   Hu, Yong ^a   Zhang, Yan fang ^a   Su, Ling ying ^a   Liu, Xin hong ^a   Li, Le chao ^a  

^a THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Epilepsy; Inflammation; Meta analysis

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SEIZURE; SYSTEMATIC REVIEW; TEMPORAL LOBE EPILEPSY;

CYTOKINES; EPILEPSY; HUMANS; INFLAMMATION; SEIZURES;

EID: 84862785339     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.02.070     Document Type: Article

References (53)

1. Aarli J.A. Epilepsy and the immune system. Arch. Neurol. 2000, 57:1689-1692.
2. Adibhatla R.M., Hatcher J.F. Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 2008, 49:241-268.
3. Alapirtti T., Rinta S., Hulkkonen J., Mäkinen R., Keränen T., Peltola J. Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J. Neurol. Sci. 2009, 280:94-97.
4. Bartfai T., Sanchez-Alavez M., Andell-Jonsson S., Schultzberg M., Vezzani A., Danielsson E., Conti B. Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma. Ann. N. Y. Acad. Sci. 2007, 1113:173-177.
5. Bauer B., Hartz A.M., Miller D.S. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol. Pharmacol. 2007, 71:667-675.
6. Bauer S., Cepok S., Todorova-Rudolph A., Nowak M., Köller M., Lorenz R., Oertel W.H., Rosenow F., Hemmer B., Hamer H.M. Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res. 2009, 86:82-88.
7. Baxendale S., O'Toole A. Epilepsy myths: alive and foaming in the 21st century. Epilepsy Behav. 2007, 11:192-196.
8. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10061-10065.
9. Carmeli E., Beiker R., Morad M. Nitric oxide and interlukin-6 levels in intellectual disability adults with epilepsy. Res. Dev. Disabil. 2009, 30:567-571.
10. Choi J., Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med. J. 2008, 49:1-18.
11. Crespel A., Coubes P., Rousset M.C., Brana C., Rougier A., Rondouin G., Bockaert J., Baldy-Moulinier M., Lerner-Natoli M. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res. 2002, 952:159-169.
12. Deng X., Luyendyk J.P., Ganey P.E., Roth R.A. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacol. Rev. 2009, 61:262-282.
13. Dhir A. Novel discoveries in understanding the complexities of epilepsy and major depression. Expert Opin. Ther. Targets 2010, 14:109-115.
14. Fabene P.F., Bramanti P., Constantin G. The emerging role for chemokines in epilepsy. J. Neuroophthalmol. 2010, 224:22-27.
15. Fukuda M., Suzuki Y., Ishizaki Y., Kira R., Kikuchi C., Watanabe S., Hino H., Morimoto T., Hara T., Ishii E. Interleukin-1beta enhances susceptibility to hyperthermia-induced seizures in developing rats. Seizure 2009, 18:211-214.
16. Gidal B.E., Reiss W.G., Liao J.S., Pitterle M.E. Changes in interleukin-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokinetics. Ann. Pharmacother. 1996, 30:545-546.
17. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
18. Hulkkonen J., Koskikallio E., Rainesalo S., Keränen T., Hurme M., Peltola J. The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Res. 2004, 59:199-205.
19. Ichiyama T., Okada K., Lipton J.M., Matsubara T., Hayashi T., Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 2000, 857:246-251.
20. Ishii H., Yoshida M. Inflammatory cytokines. Nippon Rinsho 2010, 68:819-822.
21. Jauneau A.C., Ischenko A., Chatagner A., Benard M., Chan P., Schouft M.T., Patte C., Vaudry H., Fontaine M. Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes. J. Neuroinflammation 2006, 4:3-8.
22. Kauffman M.A., Moron D.G., Consalvo D., Bello R., Kochen S. Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis. Genet. Med. 2008, 10:83-88.
23. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000, 342:314-319.
24. Lasson W. Mechanisms of drug resistance in epilepsy. Przgl Leκ. 2006, 63:1218-1220.
25. Lazarowski A., Czornyj L., Lubienieki F. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy. Epilepsia 2007, 48:140-149.
26. Lehtimäki K.A., Keränen T., Huhtala H., Hurme M., Ollikainen J., Honkaniemi J., Palmio J., Peltola J. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J. Neuroophthalmol. 2004, 152:121-125.
27. Lehtimäki K.A., Keränen T., Palmio J., Mäkinen R., Hurme M., Honkaniemi J., Peltola J. Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol. Scand. 2007, 116:226-230.
28. Lehtimäki K.A., Keränen T., Palmio J., Peltola J. Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures. Neuroimmunomodulation 2010, 17:19-22.
29. Liimatainen S., Fallah M., Kharazmi E., Peltola M., Peltola J. Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J. Neurol. 2009, 256:796-802.
30. Luzzatti C., Whitaker H. Jean-Baptiste Bouillaud, Claude-François Lallemand, and the role of the frontal lobe: location and mislocation of language in the early 19th century. Arch. Neurol. 2001, 58:1157-1162.
31. Majoie H.J., Rijkers K., Berfelo M.W., Hulsman J.A., Myint A., Schwarz M., Vles J.S. Vagus nerve stimulation in refractory epilepsy: effects on pro- and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation 2010, 18:52-56.
32. Massi P., Vaccani A., Parolaro D. Cannabinoids, immune system and cytokine network. Curr. Pharm. Des. 2006, 12:3135-3146.
33. Mazarati A.M., Pineda E., Shin D., Tio D., Taylor A.N., Sankar R. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta. Neurobiol. Dis. 2010, 37:461-467.
34. Młodzikowska-Albrecht J., Steinborn B., Zarowski M. Cytokines, epilepsy and epileptic drugs-is there a mutual influence. Pharmacol. Rep. 2007, 59:129-138.
35. Molinero A., Penkowa M., Hernández J., Camats J., Giralt M., Lago N., Carrasco J., Campbell I.L., Hidalgo J. Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6. J. Neuropathol. Exp. Neurol. 2003, 62:315-328.
36. Ozkara C., Uzan M., Tanriverdi T., Baykara O., Ekinci B., Yeni N., Kafadar A., Buyru N. Lack of association between IL-1beta/alpha gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis. Seizure 2006, 15:288-291.
37. Pacifici R., Paris L., Di Carlo S., Bacosi A., Pichini S., Zuccaro P. Cytokine production in blood mononuclear cells from epileptic patients. Epilepsia 1995, 36:384-387.
38. Peltola J., Hurme M., Miettinen A., Keränen T. Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 1998, 31:129-133.
39. Peltola J., Laaksonen J., Haapala A.M., Hurme M., Rainesalo S., Keränen T. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure 2002, 11:44-46.
40. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M., Lindholm D., Keränen T. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 2000, 41:205-211.
41. Ravizza T., Gagliardi B., Noé F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
42. Riazi K., Galic M.A., Pittman Q.J. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res. 2010, 89:34-42.
43. Rijkers K., Majoie H.J., Hoogland G., Kenis G., De Baets M., Vles J.S. The role of interleukin-1 in seizures and epilepsy: a critical review. Exp. Neurol. 2009, 216:258-271.
44. Roberts D.J., Goralski K.B. A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin. Drug Metab. Toxicol. 2008, 4:1-20.
45. Sinha S., Patil S.A., Jayalekshmy V., Satishchandra P. Do cytokines have any role in epilepsy. Epilepsy Res. 2008, 82:171-176.
46. Steinman L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 2004, 5:575-581.
47. Thom M., Eriksson S., Martinian L., Caboclo L.O., McEvoy A.W., Duncan J.S., Sisodiya S.M. Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features. J. Neuropathol. Exp. Neurol. 2009, 68:928-938.
48. Tomoum H.Y., Badawy N.M., Mostafa A.A., Harb M.Y. Plasma interleukin-1beta levels in children with febrile seizures. J. Child Neurol. 2007, 22:689-692.
49. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 2008, 22:797-803.
50. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743.
51. Vezzani A., Janigro D. Leukocyte-endothelial adhesion mechanisms in epilepsy: cheers and jeers. Epilepsy Curr. 2009, 9:118-121.
52. Vezzani A., Ravizza T., Balosso S., Aronica E. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 2008, 49:24-32.
53. Ziegler D.R., Oliveira D.L., Pires C., Ribeiro L., Leite M., Mendez A., Gonçalves D., Tramontina F., Portela L.V., Wofchuk S.T., Perry M.L., Gonçalves C.A. Ketogenic diet fed rats have low levels of S100B in cerebrospinal fluid. Neurosci. Res. 2004, 50:375-379.